|
Index of reports
> Cases with Product Quality Issue (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Celestone (Betamethasone) where reactions include product quality issue. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Celestone side effects in 34 year old female
Reported by a pharmacist from Australia on 2012-06-25
Patient: 34 year old female
Reactions: Flushing, Product Quality Issue, Caesarean Section, Dyspnoea Exertional, Body Temperature Increased, Maternal Exposure During Pregnancy, Feeling Hot
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Celestone
Dosage: 22.8 mg; qd; im
Indication: Prophylaxis
Start date: 2012-02-28
Celestone
Possible Celestone side effects in 34 year old female
Reported by a pharmacist from Australia on 2012-03-19
Patient: 34 year old female
Reactions: Product Quality Issue, Body Temperature Increased, Maternal Exposure During Pregnancy, Erythema, Flushing, Dyspnoea Exertional, Caesarean Section, Feeling Hot, NO Reaction ON Previous Exposure To Drug
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Celestone
Dosage: 11.4 mg;bid;im
Indication: Prophylaxis
Start date: 2012-02-28
Celestone
Possible Celestone side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-07
Patient: 43 year old male, weighing 152.4 kg (335.3 pounds)
Reactions: Pulmonary Hypertension, Electrocardiogram T Wave Amplitude Decreased, Impaired Work Ability, Wound, Constipation, Chronic Obstructive Pulmonary Disease, Pericardial Effusion, Myalgia, Fatigue, Oedema, White Blood Cell Count Increased, Cardiac Failure Congestive, Product Quality Issue, Blood Pressure Increased, Back Pain, Blood Urine Present, Cellulitis, Neutrophil Count Increased, Drug Hypersensitivity, Decreased Activity, Skin Hypopigmentation, Rash, Diverticulum Intestinal, Myopathy, Heart Rate Increased, Infection
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Celestone
Dosage: intramuscular
Indication: Dermatitis Contact
Start date: 2011-03-23
End date: 2011-03-23
Dexamethasone Sodium Phosphate
Dosage: 8 mg x 2 doses
Indication: Dermatitis Contact
Start date: 2011-03-23
End date: 2011-04-01
Dexamethasone Sodium Phosphate
Dosage: 8 mg x 2 doses
Indication: Dermatitis Contact
Start date: 2011-03-23
End date: 2011-04-01
Other drugs received by patient: Furosemide; Adipex; Viagra; Potassium Chloride; Losartan Potassium
|
